CAMS
MCID: CRB210
MIFTS: 28

Cerebrofacial Arteriovenous Metameric Syndrome (CAMS)

Categories: Cardiovascular diseases, Fetal diseases, Neuronal diseases, Rare diseases

Aliases & Classifications for Cerebrofacial Arteriovenous Metameric Syndrome

MalaCards integrated aliases for Cerebrofacial Arteriovenous Metameric Syndrome:

Name: Cerebrofacial Arteriovenous Metameric Syndrome 58
Cams 58

Classifications:

Orphanet: 58  
Rare neurological diseases
Rare circulatory system diseases
Developmental anomalies during embryogenesis


External Ids:

ICD10 via Orphanet 33 Q28.2
Orphanet 58 ORPHA141189

Summaries for Cerebrofacial Arteriovenous Metameric Syndrome

MalaCards based summary : Cerebrofacial Arteriovenous Metameric Syndrome, also known as cams, is related to cerebrofacial arteriovenous metameric syndrome type 3 and cerebrofacial arteriovenous metameric syndrome type 1. The drugs Tocopherol and Vitamin E have been mentioned in the context of this disorder. Affiliated tissues include endothelial, breast and brain.

Related Diseases for Cerebrofacial Arteriovenous Metameric Syndrome

Diseases in the Cerebrofacial Arteriovenous Metameric Syndrome family:

Cerebrofacial Arteriovenous Metameric Syndrome Type 3 Cerebrofacial Arteriovenous Metameric Syndrome Type 1

Diseases related to Cerebrofacial Arteriovenous Metameric Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 479)
# Related Disease Score Top Affiliating Genes
1 cerebrofacial arteriovenous metameric syndrome type 3 12.7
2 cerebrofacial arteriovenous metameric syndrome type 1 12.7
3 cataract 5, multiple types 12.2
4 wyburn-mason syndrome 12.1
5 cobb syndrome 11.7
6 cerebral cavernous malformations 11.4
7 hair whorl 10.9
8 arteriovenous malformation 10.8
9 subacute delirium 10.5
10 arteriovenous malformations of the brain 10.4
11 ataxia and polyneuropathy, adult-onset 10.4
12 hemangioma 10.4
13 capillary hemangioma 10.4
14 hypopituitarism 10.4
15 meningoencephalocele 10.4
16 mandibular arteriovenous malformation 10.4
17 colorectal cancer 10.3
18 neuroblastoma 10.3
19 suppression amblyopia 10.2
20 amblyopia 10.2
21 squamous cell carcinoma 10.2
22 adenocarcinoma 10.2
23 back pain 10.2
24 breast cancer 10.2
25 osteoarthritis 10.2
26 ovarian cancer 10.2
27 pancreatic cancer 10.2
28 slipped capital femoral epiphysis 10.2
29 chronic pain 10.2
30 lung cancer 10.2
31 scoliosis 10.2
32 measles 10.2
33 lymphoma 10.1
34 melanoma 10.1
35 small cell cancer of the lung 10.1
36 anxiety 10.1
37 aging 10.1
38 idiopathic scoliosis 10.1
39 bone resorption disease 10.1
40 adenoma 10.1
41 scoliosis, isolated 1 10.1
42 myeloma, multiple 10.1
43 renal cell carcinoma, nonpapillary 10.0
44 inflammatory bowel disease 10.0
45 autoimmune disease 10.0
46 developmental dysplasia of the hip 1 10.0
47 migraine with or without aura 1 10.0
48 prostate cancer 10.0
49 ocular motor apraxia 10.0
50 helix syndrome 10.0

Graphical network of the top 20 diseases related to Cerebrofacial Arteriovenous Metameric Syndrome:



Diseases related to Cerebrofacial Arteriovenous Metameric Syndrome

Symptoms & Phenotypes for Cerebrofacial Arteriovenous Metameric Syndrome

Drugs & Therapeutics for Cerebrofacial Arteriovenous Metameric Syndrome

Drugs for Cerebrofacial Arteriovenous Metameric Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 44)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Tocopherol Approved, Investigational Phase 2 1406-66-2, 54-28-4 14986
2
Vitamin E Approved, Nutraceutical, Vet_approved Phase 2 59-02-9 14985
3 Tocotrienol Investigational Phase 2 6829-55-6
4 Vitamins Phase 2
5 Micronutrients Phase 2
6 Trace Elements Phase 2
7 Antioxidants Phase 2
8 Nutrients Phase 2
9 Tocotrienols Phase 2
10 Tocopherols Phase 2
11 Protective Agents Phase 2
12
Daunorubicin Approved 20830-81-3 30323
13
Anastrozole Approved, Investigational 120511-73-1 2187
14
Etoposide Approved 33419-42-0 36462
15
Mitoxantrone Approved, Investigational 65271-80-9 4212
16
Idarubicin Approved 58957-92-9 42890
17
Cytarabine Approved, Experimental, Investigational 147-94-4, 65-46-3 6253
18
Lenograstim Approved, Investigational 135968-09-1
19
Sargramostim Approved, Investigational 83869-56-1, 123774-72-1
20
Dasatinib Approved, Investigational 302962-49-8 3062316
21
Vitamin C Approved, Nutraceutical 50-81-7 5785 54670067
22 Molgramostim Investigational 99283-10-0
23
Homoharringtonine 285033
24 Antineoplastic Agents, Hormonal
25 Hormones
26 Estrogen Antagonists
27 Flax
28 Hormone Antagonists
29 Phytoestrogens
30 Estrogens
31 Aromatase Inhibitors
32 Estrogen Receptor Antagonists
33 Etoposide phosphate
34 Protein Kinase Inhibitors
35 Immunologic Factors
36 Adjuvants, Immunologic
37 Anti-Infective Agents
38 Aclacinomycins
39 Immunosuppressive Agents
40 Anti-Bacterial Agents
41 Antiviral Agents
42 Analgesics
43 Antibiotics, Antitubercular
44 Antimetabolites

Interventional clinical trials:

(show all 33)
# Name Status NCT ID Phase Drugs
1 Neuroplasticity of Brain-Asphyxiated Infants: Efficacy of Intervention Completed NCT00006516 Phase 2
2 Relaxation Response With Acupuncture for HIV Patients Completed NCT00064740 Phase 2
3 Effect of High Dose Vitamin E on Carotid Atherosclerosis Completed NCT00010699 Phase 2 Vitamin E
4 "Collaborative Assessment and Management of Suicidality" (CAMS) in Comparison to "Treatment as Usual" (TAU) for Suicidal Patients: a Randomized Controlled Trial Unknown status NCT02685943
5 Investigating the Effects of an Added Parent Component to Cognitive Behavior Therapy for Youth With Anxiety Disorders Unknown status NCT02160444
6 Using Technology to Expand and Enhance Applied Behavioral Analysis Programs for Children With Autism in Military Families Unknown status NCT01614275
7 Efficacy Analysis of Comparison of CAMS-2005 Trial and CAMS-2009 Trial for Pediatric Acute Myeloid Leukemia Completed NCT03165851
8 Patient and Provider Outcomes of E-Learning Training in Collaborative Assessment and Management of Suicidality Completed NCT00905827
9 CAMS Relational Agent System for Suicide Prevention Completed NCT03072875
10 A Randomized Clinical Trial of the Collaborative Assessment and Management of Suicidality Versus Enhanced Care as Usual for Suicidal Soldiers Completed NCT01300169
11 Efficacy of Dialectical Behavior Therapy in Patient With Self Harming Behavior and Traits Within the Spectrum of Borderline Personality Disorder. Completed NCT01512602
12 Intensive Outpatient Treatment for Suicidal Veterans: A Randomized Clinical Trial and Feasibility Investigation Completed NCT01334372
13 Developing Adaptive Interventions for Suicidal College Students Seeking Treatment - SMART Completed NCT02442869
14 A Double Arm Study to Evaluate the Effectiveness of NEM Compositions for the Treatment of Joint and Connective Tissue Pain Completed NCT00750854
15 Effect of Localized Muscle Cooling on Balance in Healthy Individuals Completed NCT03788135
16 Infection, Sepsis and Meningitis in Surinamese Neonates Completed NCT02486783
17 A Multi-Center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effectiveness and Safety of Natural Eggshell Membrane (NEM) in the Treatment of Pain & Stiffness Associated With Moderate Osteoarthritis of the Knee Completed NCT00750477
18 A Single Arm Pilot Study to Evaluate the Effectiveness of Eggshell Membrane Compositions for the Treatment of Pain Associated With Connective Tissue and Joints Completed NCT00750230
19 Flaxseed vs. Aromatase Inhibitors: Breast Tumor Characteristics and Prognosis Completed NCT00612560 Anastrozole;Placebo
20 Correlation Between Serum Markers of Unstable Plaque and Virtual Histology of Unstable Plaque Visualized by IVUS Completed NCT00466050
21 Effects of Gait Rehabilitation With Dual Task in Patients With Parkinson's Disease: a Randomized Controlled Trial Completed NCT04038866
22 CAMS Relational Agent System (CAMS-RAS) for Suicide Prevention Recruiting NCT03584386
23 Intravascular Ultrasound Prediction of Myocardial Size and Coronary Computed Tomography-Derived Ischemic Burden for Coronary Lesion Recruiting NCT02845505
24 The Efficiency of CAMS-2016 Trial for the Newly Diagnosed Pediatric Acute Myeloid Leukemia: A Prospective Single Centre Trial From China Recruiting NCT03173612 Dasatinib
25 Mindfulness Meditation for the Treatment of Women With Comorbid PTSD and SUD Recruiting NCT02755103
26 Pilot Study of the Collaborative Assessment and Management of Suicidality - Group (CAMS-G) Active, not recruiting NCT03682406
27 Prevalence of Self-disclosed Knee Trouble and Use of Treatments Among Elderly Individuals From Frederiksberg Municipality - A Prospective Cohort Study Active, not recruiting NCT03472300
28 Pilot Testing of Food Images in Children Enrolling by invitation NCT03338634
29 Improving Emotional Well-Being by Way of Alternative Therapies for Refugees Enrolling by invitation NCT03515564
30 A Pilot Study of Collaborative Assessment and Management of Suicidality (CAMS—Jobes, 2006; 2016) With Suicidal Children ("CAMS-4Kids") Not yet recruiting NCT04119648
31 A Comparison of Anatomically Aligned Versus Conventional in Unilateral Total Knee Arthroplasty Not yet recruiting NCT04181528
32 Comparison of Anatomically Aligned and Conventional Total Knee Arthroplasty in the Same Patients Not yet recruiting NCT04181216
33 Comparison of Radiological, Clinical, Functional Outcomes Between Anatomically Aligned Total Knee Arthroplasty and Conventional Total Knee Arthroplasty Not yet recruiting NCT04183985

Search NIH Clinical Center for Cerebrofacial Arteriovenous Metameric Syndrome

Genetic Tests for Cerebrofacial Arteriovenous Metameric Syndrome

Anatomical Context for Cerebrofacial Arteriovenous Metameric Syndrome

MalaCards organs/tissues related to Cerebrofacial Arteriovenous Metameric Syndrome:

40
Endothelial, Breast, Brain, Lung, Monocytes, Bone, Heart

Publications for Cerebrofacial Arteriovenous Metameric Syndrome

Articles related to Cerebrofacial Arteriovenous Metameric Syndrome:

(show top 50) (show all 2281)
# Title Authors PMID Year
1
A call for abstracts for The Lancet-CAMS Health conference. 61
31868617 2020
2
Abnormally high expression of HOXA2 as an independent factor for poor prognosis in glioma patients. 61
32436804 2020
3
Novel Hexb-based tools for studying microglia in the CNS. 61
32541832 2020
4
Microsporidia Can Acquire Lamin-like Intermediate Filaments and Cell Adhesion Catenin-cadherin Complexes from the Host (?). 61
32498127 2020
5
TRPM5 Negatively Regulates Calcium-Dependent Responses in Lipopolysaccharide-Stimulated B Lymphocytes. 61
32521253 2020
6
Enhancement of aberrantly modified integrin‑mediated cell motility in multicellular tumor spheroids. 61
32236635 2020
7
Discovery of (1H-Pyrazolo[3,4-c]pyridin-5-yl)sulfonamide Analogues as Hepatitis B Virus Capsid Assembly Modulators by Conformation Constraint. 61
32421339 2020
8
Magnetic alignment enhances homing efficiency of hunting dogs. 61
32539933 2020
9
Complementary and Alternative Medicine Use Among Pediatric Emergency Department Patients in Singapore. 61
32530833 2020
10
Transcriptional changes of Pacific oyster Crassostrea gigas reveal essential role of calcium signal pathway in response to CO2-driven acidification. 61
32570066 2020
11
Complementary and Alternative Medicine in Radiotherapy: A Comprehensive Review. 61
32568977 2020
12
Understanding Therapists' Work With Suicidal Patients: An Examination of Qualitative Data. 61
29745779 2020
13
Medical cannabis use in the Australian community following introduction of legal access: the 2018-2019 Online Cross-Sectional Cannabis as Medicine Survey (CAMS-18). 61
32513180 2020
14
Alterations of transcriptome signatures in head trauma-related neurodegenerative disorders. 61
32483284 2020
15
Overexpression of LBX2 associated with tumor progression and poor prognosis in colorectal cancer. 61
32382328 2020
16
Assessment of knee pain from MR imaging using a convolutional Siamese network. 61
32055951 2020
17
Aberrant ETS-1 signalling impedes the expression of cell adhesion molecules and matrix metalloproteinases in non-segmental vitiligo. 61
32350934 2020
18
Anxiety Symptoms Differ in Youth With and Without Tic Disorders. 61
32519083 2020
19
Polymorphisms in Neuronal Growth Regulator 1 and Otoancorin Alternate the Susceptibility to Lung Cancer in Chinese Nonsmoking Females. 61
32552051 2020
20
UVB induces cutaneous squamous cell carcinoma progression by de novo ID4 methylation via methylation regulating enzymes. 61
32574963 2020
21
[Protecting Medical Professionals from Infection During the Coronavirus Pandemic: Overnight Implementation of Virtual Medical Boards]. 61
32413909 2020
22
Cell Theranostics on Mesoporous Silicon Substrates. 61
32466284 2020
23
Bayesian geostatistical modelling of high-resolution NO2 exposure in Europe combining data from monitors, satellites and chemical transport models. 61
32179313 2020
24
The roles of the site-2 protease Eep in Staphylococcus aureus. 61
32457050 2020
25
Effects of social stress on performance and strain in complex multiple task environments. 61
32367768 2020
26
Persistent Hyperactivation of Endothelial Cells in Patients with Alcoholic Hepatitis. 61
32246771 2020
27
[Comparison of autologous versus matched sibling donor stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia]. 61
32536133 2020
28
[Efficacy and prognostic factors in children with non-core binding factor acute myeloid leukemia]. 61
32434642 2020
29
Trafficking and Activity of Glutamate and GABA Receptors: Regulation by Cell Adhesion Molecules. 61
32449484 2020
30
Scalable Synthesis of Microsized, Nanocrystalline Zn0.9 Fe0.1 O-C Secondary Particles and Their Use in Zn0.9 Fe0.1 O-C/LiNi0.5 Mn1.5 O4 Lithium-Ion Full Cells. 61
32286730 2020
31
A Preliminary Precision Treatment Rule for Remission of Suicide Ideation. 61
31814153 2020
32
Antidepressant Use in a 3- to 12-Year Follow-up of Anxious Youth: Results from the CAMELS Trial. 61
32253545 2020
33
Molecular mechanisms regulating synaptic specificity and retinal circuit formation. 61
32267095 2020
34
Antiviral Properties and Mechanism of Action Studies of the Hepatitis B Virus Capsid Assembly Modulator JNJ-56136379. 61
32094138 2020
35
Identification of key genes and pathways associated with feed efficiency of native chickens based on transcriptome data via bioinformatics analysis. 61
32272881 2020
36
Beyond the orthodox/CAM dichotomy: Exploring therapeutic decision making, reasoning and practice in the therapeutic landscapes of elite sports medicine. 61
32179363 2020
37
KLF4 alleviates cerebral vascular injury by ameliorating vascular endothelial inflammation and regulating tight junction protein expression following ischemic stroke. 61
32264912 2020
38
Correction to: The Capacity of Generic Musculoskeletal Simulations to Predict Knee Joint Loading Using the CAMS-Knee Datasets. 61
32125572 2020
39
Collaborative Assessment and Management of Suicidality (CAMS) compared to enhanced treatment as usual (E-TAU) for suicidal patients in an inpatient setting: study protocol for a randomized controlled trial. 61
32321477 2020
40
[Progress on the role of synaptic cell adhesion molecules in stress]. 61
32328615 2020
41
The Capacity of Generic Musculoskeletal Simulations to Predict Knee Joint Loading Using the CAMS-Knee Datasets. 61
32002734 2020
42
Circulating tumor DNA predicts response in Chinese patients with relapsed or refractory classical hodgkin lymphoma treated with sintilimab. 61
32304999 2020
43
Influence of treatments on cell adhesion molecules in patients with systemic lupus erythematosus and rheumatoid arthritis: a review. 61
31820195 2020
44
CD44 Can Compensate for IgSF11 Deficiency by Associating with the Scaffold Protein PSD-95 during Osteoclast Differentiation. 61
32290171 2020
45
A Randomized Controlled Trial of the Collaborative Assessment and Management of Suicidality (CAMS) Versus Treatment as Usual (TAU) for Suicidal College Students. 61
32275480 2020
46
Cancer-associated mutations in endometriosis: shedding light on the pathogenesis and pathophysiology. 61
32154564 2020
47
A novel engagement of suicidality in the emergency department: Virtual Collaborative Assessment and Management of Suicidality. 61
29934033 2020
48
Deficiency of sphingomyelin synthase 2 prolongs survival by the inhibition of lymphoma infiltration through ICAM-1 reduction. 61
31970839 2020
49
Systematic identification of CDC34 that functions to stabilize EGFR and promote lung carcinogenesis. 61
32114396 2020
50
The Impact of an Evidence-Based Education on Complementary and Alternative Medicine Usage in People with Cancer: Pilot Study. 61
32170577 2020

Variations for Cerebrofacial Arteriovenous Metameric Syndrome

Expression for Cerebrofacial Arteriovenous Metameric Syndrome

Search GEO for disease gene expression data for Cerebrofacial Arteriovenous Metameric Syndrome.

Pathways for Cerebrofacial Arteriovenous Metameric Syndrome

GO Terms for Cerebrofacial Arteriovenous Metameric Syndrome

Sources for Cerebrofacial Arteriovenous Metameric Syndrome

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....